Table of Content




1. Research Methodology and Executive Summary
1.1 Research Methodology
1.2 Executive Summary


2. Strategic Recommendations
2.1 Focus on Investing in Biotech Research & Development for Next Generation Biologics
2.2 Focus on Demand for Affordability and Improved Access


3. Biologics Market : Product Outlook


4. Global Biologics Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2015-2025


5. Global Biologics Market Segmentation - By Product Type, By Application, By End User
5.1 Competitive Scenario of Global Biologics: By Product Type
5.2 Vaccine – Market Size and Forecast (2015-2025)
5.3 Monoclonal Antibodies - Market Size and Forecast (2015-2025)
5.4 Recombinant Hormones and Proteins - Market Size and Forecast (2015-2025)
5.5 Cellular and Gene Based - Market Size and Forecast (2015-2025)\
5.6 Others - Market Size and Forecast (2015-2025)


6. Global Biologics Market Segmentation - By Application
6.1 Competitive Scenario of Global Biologics: By Application
6.2 Cancer – Market Size and Forecast (2015-2025)
6.3 Rare and Autoimmune Disease - Market Size and Forecast (2015-2025)
6.4 Infectious Diseases – Market Size and Forecast (2015-2025)
6.5 Others – Market Size and Forecast (2015-2025)


7. Global Biologics Market Segmentation - By End User
7.1 Competitive Scenario of Global Biologics: By End User
7.2 Hospitals – Market Size and Forecast (2015-2025)
7.3 Clinics - Market Size and Forecast (2015-2025)
7.4 Diagnostic Centers – Market Size and Forecast (2015-2025)
7.5 Others – Market Size and Forecast (2015-2025)


8. Global Biologics Market: Regional Analysis
8.1 Competitive Scenario of Global Biologics: By Region


9. North America Biologics Market: Segmentation By Product Type, By Application, By End User (2015-2025)
9.1 North America Biologics Market: Size and Forecast (2015-2025), By Value
9.2 North America Biologics Market – Prominent Companies
9.3 Market Segmentation By Product Type (Vaccine, Monoclonal Ab, Recombinant Hormones and Proteins, Cellular and Gene Based, Others)
9.4 Market Segmentation By Application (Cancer, Rare and Autoimmune Disease, Infectious Disease, Others)
9.5 Market Segmentation By End User (Hospital, Clinics, Diagnostic Centers, Others)

9.6 North America Biologics Market: Country Analysis
9.7 Market Opportunity Chart of North America Biologics Market - By Country, By Value, 2025
9.8 Competitive Scenario of North America Biologics: By Country
9.9 United States Biologics Market: Size and Forecast (2015-2025), By Value
9.10 United States Biologics Market Segmentation - By Product Type, By Application, By End User
9.11 Canada Biologics Market: Size and Forecast (2015-2025), By Value
9.12 Canada Biologics Market Segmentation - By Product Type, By Application, By End User


10. Europe Biologics Market: Segmentation By Product Type, By Application, By End User (2015-2025)
10.1 Europe Biologics Market: Size and Forecast (2015-2025), By Value
10.2 Europe Biologics Market – Prominent Companies
10.3 Market Segmentation By Product Type (Vaccine, Monoclonal Ab, Recombinant Hormones and Proteins, Cellular and Gene Based, Others)
10.4 Market Segmentation By Application (Cancer, Rare and Autoimmune Disease, Infectious Disease, Others)
10.5 Market Segmentation By End User (Hospital, Clinics, Diagnostic Centers, Others)

10.6 Europe Biologics Market: Country Analysis
10.7 Market Opportunity Chart of Europe Biologics Market - By Country, By Value, 2025
10.8 Competitive Scenario of North America Biologics: By Country
10.9 Germany Biologics Market: Size and Forecast (2015-2025), By Value
10.10 Germany Biologics Market Segmentation - By Product Type, By Application, By End User
10.11 France Biologics Market: Size and Forecast (2015-2025), By Value
10.12 France Biologics Market Segmentation - By Product Type, By Application, By End User
10.13 United Kingdom Biologics Market: Size and Forecast (2015-2025), By Value
10.14 United Kingdom Market Segmentation - By Product Type, By Application, By End User
10.15 Italy Biologics Market: Size and Forecast (2015-2025), By Value
10.16 Italy Biologics Market Segmentation - By Product Type, By Application, By End User


11. Asia Pacific Biologics Market: Segmentation By Product Type, By Application, By End User (2015-2025)
11.1 Asia Pacific Biologics Market: Size and Forecast (2015-2025), By Value
11.2 Asia Pacific Biologics Market – Prominent Companies
11.3 Market Segmentation By Product Type (Vaccine, Monoclonal Ab, Recombinant Hormones and Proteins, Cellular and Gene Based, Others)
11.4 Market Segmentation By Application (Cancer, Rare and Autoimmune Disease, Infectious Disease, Others)
11.5 Market Segmentation By End User (Hospital, Clinics, Diagnostic Centers, Others)

11.6 Asia Pacific Biologics Market: Country Analysis
11.7 Market Opportunity Chart of Asia Pacific Biologics Market - By Country, By Value, 2025
11.8 Competitive Scenario of Asia Pacific Biologics: By Country
11.9 China Biologics Market: Size and Forecast (2015-2025), By Value
11.10 China Biologics Market Segmentation - By Product Type, By Application, By End User
11.11 Japan Biologics Market: Size and Forecast (2015-2025), By Value
11.12 Japan Biologics Market Segmentation - By Product Type, By Application, By End User
11.13 India Biologics Market: Size and Forecast (2015-2025), By Value
11.14 India Biologics Market Segmentation - By Product Type, By Application, By End User
11.15 South Korea Biologics Market: Size and Forecast (2015-2025), By Value
11.16 South Korea Biologics Market Segmentation - By Product Type, By Application, By End User


12. Global Biologics Market Dynamics
12.1 Drivers
12.2 Restraints
12.3 Trends


13. Market Attractiveness
13.1 Market Attractiveness Chart of Global Biologics Market - By Product Type, 2025
13.2 Market Attractiveness Chart of Global Biologics Market - By Application, 2025
13.3 Market Attractiveness Chart of Global Biologics Market - By End User, 2025
13.4 Market Attractiveness Chart of Global Biologics Market - By Region, 2025


14. SWOT Analysis


15. Development of Pipeline Products


16. Competitive Landscape
16.1 Market Share Analysis


17. Company Profiles (Business Description, Financial Analysis, Business Strategy)
17.1 Eli Lilly and Company
17.2 Sanofi SA
17.3 Pfizer
17.4 Roche Holding AG
17.5 AbbVie Inc.
17.6 Amgen Inc.
17.7 Merck & Co.
17.8 Novo Nordisk
17.9 Bristol-Myers Squibb Company
17.10 Johnson & Johnson